Ocular Therapeutix, Inc. (OCUL) Documents: SEC Filings, Investor Presentations & Press Releases

Ocular Therapeutix, Inc. (OCUL) documents, SEC filings and the IR site together: 87 documents, newest first; latest 2026-08-03. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site

Date	Type	Document
2026-08-03	Deck	Investor presentation · Aug 2026
2026-08-03	8-K	Form 8-K, Item 2.02 results
2026-08-03	10-Q	Form 10-Q for the quarter ended Jun 30
2026-06-19	Transcript	Earnings call transcript
2026-06-12	8-K	Form 8-K, Item 5.02
2026-05-05	8-K	Form 8-K, Item 2.02 results
2026-05-05	10-Q	Form 10-Q for the quarter ended Mar 31
2026-04-30	Proxy	Definitive proxy statement
2026-02-27	8-K	Form 8-K, Item 7.01
2026-02-05	8-K	Form 8-K, Item 2.02 results
2026-02-05	10-K	Annual report on Form 10-K, FY25
2026-01-23	8-K	Form 8-K, Item 5.02
2025-12-18	8-K	Form 8-K, Item 8.01
2025-12-05	8-K	Form 8-K, Item 8.01
2025-11-04	8-K	Form 8-K, Item 2.02 results
2025-11-04	10-Q	Form 10-Q for the quarter ended Sep 30
2025-09-30	8-K	Form 8-K, Item 8.01
2025-09-30	8-K	Form 8-K, Item 1.01
2025-09-30	Transcript	FY25 earnings call transcript
2025-08-05	8-K	Form 8-K, Item 2.02 results
2025-08-05	10-Q	Form 10-Q for the quarter ended Jun 30
2025-06-11	8-K	Form 8-K, Item 5.02
2025-05-05	8-K	Form 8-K, Item 2.02 results
2025-05-05	10-Q	Form 10-Q for the quarter ended Mar 31
2025-04-29	Proxy	Definitive proxy statement
2025-03-03	8-K	Form 8-K, Item 2.02 results
2025-03-03	10-K	Annual report on Form 10-K, FY24
2025-02-14	8-K	Form 8-K, Item 5.02
2024-11-14	8-K	Form 8-K, Item 2.02 results
2024-11-14	10-Q	Form 10-Q for the quarter ended Sep 30
2024-10-09	8-K	Form 8-K, Item 5.02
2024-09-03	8-K	Form 8-K, Item 5.02
2024-08-07	8-K	Form 8-K, Item 2.02 results
2024-08-07	10-Q	Form 10-Q for the quarter ended Jun 30
2024-06-14	8-K	Form 8-K, Item 5.02
2024-06-03	8-K	Form 8-K, Item 2.05
2024-05-07	8-K	Form 8-K, Item 2.02 results
2024-05-07	10-Q	Form 10-Q for the quarter ended Mar 31
2024-04-29	Proxy	Definitive proxy statement
2024-04-18	8-K	Form 8-K, Item 5.02

OCUL overview · OCUL earnings · OCUL financials · OCUL KPIs · OCUL ownership · OCUL peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.